| 靶点: |
IC50: 10.7 μM (Epac1), 66 μM (Epac2(B)) |
| 体内研究: |
CE3F4 (1-3 mg/kg;通过颈内静脉导管) 抑制心房颤动 (AF),CE3F4 (3 mg/kg;静脉注射) 抑制室性心律失常。 CE3F4 (10 mg/kg;iv) 改善小鼠心肌梗死后的心功能。 |
| 参考文献: |
1. Courilleau D, et al. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1). Biochem Biophys Res Commun. 2013 Oct 25;440(3):443-8. 2. Courilleau D, et al. Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac. J Biol Chem. 2012 Dec 28;287(53):44192-202. 3. Pratt EP, et al. Ca2+ influx through L-type Ca2+ channels and Ca2+-induced Ca2+ release regulate cAMP accumulation and Epac1-dependent ERK 1/2 activation in INS-1 cells. Mol Cell Endocrinol. 2016 Jan 5;419:60-71. 4. Prajapati R, et al. Usefulness of Exchanged Protein Directly Activated by cAMP (Epac)1-Inhibiting Therapy for Prevention of Atrial and Ventricular Arrhythmias in Mice. Circ J. 2019;83(2):295-303. 5. Abstract 17548: Inhibition of Exchange Protein 1 Directly Activated by cAMP (Epac1) is Cardioprotective Against Ischemia-reperfusion Injury |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.849 ml |
14.245 ml |
28.489 ml |
| 5 mM |
0.57 ml |
2.849 ml |
5.698 ml |
| 10 mM |
0.285 ml |
1.424 ml |
2.849 ml |
| 50 mM |
0.057 ml |
0.285 ml |
0.57 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |